Matthew Ladda

, Canada


Presentations

Efficacy and safety of guselkumab in the treatment of moderate-to-severe plaque psoriasis in real-world clinical practice 09 October 2019 00:00 - 00:00
Dose optimization of brodalumab in moderate-to-severe plaque psoriasis 09 October 2019 00:00 - 00:00

Abstracts

Efficacy and safety of guselkumab in the treatment of moderate-to-severe plaque psoriasis in real-world clinical practice Psoriasis More
Dose optimization of brodalumab in moderate-to-severe plaque psoriasis Psoriasis More